Skip to main content

Animations

MJFF Publications

6841 - 6850 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2022
  • 2024
  • 2023
  • 2019
  • 2018
  • 2014
  • 2020
  • 2016
  • 2019
  • Summary Details
    RESTRICTED
    Title: Tetrabenazine‐induced acute dystonic reaction during the treatment of comorbid tics in a young woman with autism spectrum disorder
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/pcn.13705
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/bpa.13130
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Diversity of dynamic voltage patterns in neuronal dendrites revealed by nanopipette electrophysiology
    Journal Name: Nanoscale
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d2nr03475a
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Journal Name: Molecular Genetics and Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001
    Citation Count: 37
  • Summary Details
    OPEN
    Title: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00064
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Resistance of naturally secreted α‐synuclein to proteolysis
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.13-245852
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51269
    Citation Count: 52
  • Summary Details
    OPEN
    Title: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0066-z
    Citation Count: 171
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.